Hugo Gagnon

Hugo Gagnon is the Chief Scientific Officer of Allumiqs. Allumiqs was created in early 2022. Previously, he served as the CEO and co-founder of PhenoSwitch Bioscience, which was acquired by Proteoform Scientific to create Allumiqs. Hugo has been the driving force behind the innovative LC-MS/MS services offerings tailored with deep data analytics insights and high-quality reputation the company has developed within biotech, omics, and mass spec industries.

Content by Hugo Gagnon:

Techniques & Tools Mass Spectrometry

Defying Uncertainty in Gene Therapy

11/28/2022 | Hugo Gagnon

How MS-based technology is allowing researchers to characterize proteins and gene editing off-target effects with greater sensitivity and reliability

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Analytical Scientist magazine